| Literature DB >> 35098254 |
Riccardo Bortoletto1, Gianfranco Di Gennaro2, Giulia Antolini1, Federica Mondini1, Laura Passarella1, Valentina Rizzo1, Marta Silvestri1, Francesca Darra3, Leonardo Zoccante1, Marco Colizzi1,4,5.
Abstract
COVID-19 pandemic may affect children's mental health. Children <18 years in-patiently admitted for mental health emergencies between March 2020 and June 2021 were compared to those admitted in the same period of 2018-2019 in terms of sociodemographic and clinical characteristics. There were 49 admissions in the pre-pandemic period and 60 in the pandemic period (IRR: 1.22; 95% CI: 0.84-1.79), with the latter more likely to have a family history of psychiatric disorders, a personal history of physical disturbances, present with suicidal risk, and being diagnosed with an externalizing disorder. This study underscores the increased need for pediatric mental health services.Entities:
Keywords: Child and adolescent neuropsychiatry; Psychopharmacological therapy; Risk factors
Year: 2022 PMID: 35098254 PMCID: PMC8786397 DOI: 10.1016/j.psycom.2022.100023
Source DB: PubMed Journal: Psychiatry Res Commun ISSN: 2772-5987
Sociodemographic and clinical characteristics of pediatric in-patient admissions for mental health emergencies during the COVID-19 pandemic.
| Pre-pandemic period | Pandemic period | ||||||
|---|---|---|---|---|---|---|---|
| n | % | N | % | Total | p | ||
| Sex | Female | 30 | 45.45 | 36 | 54.55 | 66 | 0.869 |
| Male | 19 | 44.19 | 24 | 55.81 | 43 | ||
| Access day | Midweek | 23 | 33.33 | 46 | 66.67 | 69 | 0.001 |
| Weekend | 26 | 65 | 14 | 35 | 40 | ||
| Reason for admission | Anxiety-agitation | 27 | 55.1 | 22 | 44.9 | 49 | 0.145 |
| Suicidal thoughts-self-harm | 17 | 35.42 | 31 | 64.58 | 48 | ||
| Family composition | no parent-community | 8 | 47.06 | 9 | 52.94 | 17 | 0.849 |
| 1 or 2 parents | 41 | 44.57 | 51 | 55.43 | 92 | ||
| Family history of psychiatric disorders | No | 30 | 50 | 30 | 50 | 60 | 0.241 |
| Yes | 19 | 38.78 | 30 | 61.22 | 49 | ||
| Psychiatric disorders in the family | None | 31 | 50 | 31 | 50 | 65 | 0.336 |
| 1 disorder | 11 | 44 | 14 | 56 | 25 | ||
| 2 or more | 7 | 31.82 | 15 | 68.18 | 22 | ||
| Number of relatives with psychiatric disorders | None | 32 | 50.79 | 31 | 49.21 | 63 | 0.345 |
| 1 relative | 8 | 38.1 | 13 | 61.9 | 21 | ||
| 2 or more | 9 | 36 | 16 | 64 | 25 | ||
| Personal history of psychiatric disorders | No | 13 | 40.63 | 19 | 59.38 | 32 | 0.558 |
| Yes | 36 | 46.75 | 41 | 53.25 | 77 | ||
| Previous psychiatric admissions | No | 43 | 42.16 | 59 | 57.84 | 102 | 0.025∗ |
| Yes | 6 | 85.71 | 1 | 14.29 | 7 | ||
| Psychopharmacological therapy at admission | No | 19 | 43.18 | 25 | 56.82 | 44 | 0.122 |
| Monotherapy | 14 | 63.64 | 8 | 36.36 | 22 | ||
| Polytherapy | 16 | 37.21 | 27 | 62.79 | 43 | ||
| Personal history of physical disturbances | None | 24 | 35.29 | 44 | 64.71 | 68 | 0.029 |
| 1 disturbance | 16 | 64 | 9 | 36 | 25 | ||
| 2 or more | 9 | 56.25 | 7 | 43.75 | 16 | ||
| Other medication at admission | No | 41 | 44.47 | 51 | 55.43 | 92 | 0.489 |
| Yes | 8 | 47.06 | 9 | 52.94 | 17 | ||
| Traumatic events | No | 25 | 49.02 | 26 | 50.98 | 51 | 0.424 |
| Yes | 24 | 41.38 | 34 | 58.62 | 58 | ||
| Substance use | No | 41 | 43.16 | 54 | 56.84 | 95 | 0.326 |
| Yes | 8 | 57.14 | 6 | 42.86 | 14 | ||
| School attendance | Attending | 34 | 42.5 | 46 | 57.5 | 80 | 0.392 |
| Not attending | 15 | 51.72 | 14 | 48.28 | 29 | ||
| Cognitive impairment | No | 35 | 41.67 | 49 | 58.33 | 84 | 0.206 |
| Yes | 14 | 56 | 11 | 44 | 25 | ||
| Cognitive functioning | Homogeneous | 32 | 38.55 | 51 | 61.45 | 83 | 0.016 |
| Inhomogeneous | 17 | 65.38 | 9 | 34.62 | 26 | ||
| Multidisciplinary therapeutic approach | No | 24 | 33.33 | 48 | 66.67 | 72 | 0.001 |
| Yes | 25 | 67.57 | 12 | 32.43 | 37 | ||
| Behavioral diagnosis | Internalizing disorder | 18 | 51.43 | 17 | 48.57 | 35 | 0.578 |
| Externalizing disorder | 20 | 40 | 30 | 60 | 50 | ||
| Both | 11 | 45.83 | 13 | 54.17 | 24 | ||
| Psychopharmacological therapy at discharge | No | 10 | 62.5 | 6 | 37.5 | 16 | 0.308 |
| Monotherapy | 11 | 40.74 | 16 | 59.26 | 27 | ||
| Polytherapy | 28 | 42.42 | 38 | 57.58 | 66 | ||
Pre-pandemic period, March 2018–June 2019; Pandemic period, March 2020–June 2021; p, estimated by ordinary chi-squared test except ∗ estimated by Fisher's exact test.